We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Racial Disparities in Pneumococcal Vaccination in Managed Care

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00229762
First Posted: September 30, 2005
Last Update Posted: December 9, 2005
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborator:
Kaiser Permanente
Information provided by:
Centers for Disease Control and Prevention
  Purpose
The goal of the study was to determine effectiveness of a telephone reminder to increase pneumococcal vaccination in a managed care population.

Condition Intervention
Pneumococcal Disease Prevention Behavioral: phone call from nurses - informational only

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Single Group Assignment
Masking: Single
Primary Purpose: Educational/Counseling/Training
Official Title: Racial Disparities in Pneumococcal Vaccination in Managed Care: the Effects of Randomized Telephone Outreach

Further study details as provided by Centers for Disease Control and Prevention:

Primary Outcome Measures:
  • pneumococcal vaccination coverage

Estimated Enrollment: 7000
Study Start Date: March 2004
Estimated Study Completion Date: June 2005
Detailed Description:
Patients randomized to the intervention arm received a telephone call from managed care nurses asking about their pneumococcal vaccination status and whether they would like to be vaccinated. We compared six month follow-up of pneumococcal vaccination in electronic medical records for the intervention versus control group. We tested the percent vaccinated in each randomization arm using chi-square tests for proportions.
  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

- recommended for pneumococcal vaccination according to age or medical comorbidity

Exclusion Criteria:

- already known to have received pneumococcal vaccine

  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00229762


Locations
United States, Georgia
Kaiser Permanente
Atlanta, Georgia, United States, 30333
Sponsors and Collaborators
Centers for Disease Control and Prevention
Kaiser Permanente
Investigators
Principal Investigator: Carla A Winston, PhD Centers for Disease Control and Prevention
  More Information

ClinicalTrials.gov Identifier: NCT00229762     History of Changes
Other Study ID Numbers: CDC-NIP-4252
000HCJ4-2004-07797
First Submitted: September 28, 2005
First Posted: September 30, 2005
Last Update Posted: December 9, 2005
Last Verified: September 2005

Keywords provided by Centers for Disease Control and Prevention:
pneumococcal vaccination coverage with no disease or efficacy outcomes recorded

Additional relevant MeSH terms:
Pneumococcal Infections
Streptococcal Infections
Gram-Positive Bacterial Infections
Bacterial Infections
Vaccines
Immunologic Factors
Physiological Effects of Drugs